Injective climbs 4.61% as price remains above key moving averages

Traders Union
All News
Crypto News
Injective jumps 4.61% to $5.28 today

Highlights

INJ/USD shows short-term strength with price trading above its 20-day and 200-day averages, indicating bullish near-term momentum.
Oscillators are mixed, with some overbought readings clashing with neutral momentum signals, while buyers remain dominant intraday.
Price is expected to consolidate between support at 4.19 and resistance at 5.54 over the next 2–3 sessions.

Divergent momentum as overbought signals contrast with active buyers

INJ is trading above MA-20 ($5.13) and MA-200 ($4.21), but remains just under MA-50 ($5.32). Immediate support is at $5.16 (Ichimoku Kijun). The RSI stands at 52.71, and CCI also signals Buy, while Stoch RSI is Overbought. MACD, ADX, and Awesome Oscillator are Neutral. The Bull/Bear Power (BBP) is positive, showing intraday buyer dominance. High volatility persists, with price near today’s high and only a minimal gap from the previous close. Oscillators show divergence, as overbought conditions and neutral momentum contrast with evident price strength.

Balanced risk outlook as price consolidates within volatility band

Over the next 2–3 trading days, price is expected to range between $4.19 and $5.54, representing a typical volatility band relative to current levels. Both upward and downward scenarios are equally possible, with a 50% probability each. If the price breaks above resistance, further upside is likely; a break below support could trigger a move toward the lower bound of the range.

Viktoras Karapetjanc, expert at Traders Union, sees INJ displaying solid technical strength above major averages. He notes persistent buying demand, but highlights mixed oscillator signals and the absence of driving news. The expert believes the current upward bias is underpinned by recent price resilience, though volatility may produce sharp two-way moves. Karapetjanc points out that fundamental and sentiment factors look constructive for now. "With this setup, I’m inclined to favor upside continuation as long as support holds, while staying nimble in both directions due to volatility."

Earlier, analysts noted that Injective's short-term technical outlook was bearish amid heightened sell pressure and mixed momentum signals. The current shift to buyer dominance and price strength suggests that traders should monitor for a potential breakout above resistance, as continued volatility could swiftly alter the prevailing range scenario.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.